PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-10-23

Date Title Company
23-Oct-2024 Zomedica to Report Third Quarter 2024 Financial Results and Provide Business Update on November 7th at 4:30 p.m. ET AccessWire
23-Oct-2024 SpeeDx Appoints Jeremy Stackawitz as Chief Executive Officer to Drive Global Expansion of Its Molecular Diagnostics Solutions AccessWire
23-Oct-2024 Buckeye Medical Technologies Receives Fifth Patent for AnatotempSC Anatomic Dental Implant Healing Abutment Scan Body AccessWire
23-Oct-2024 CNS Pharmaceuticals Announces Pricing of $3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules AccessWire
23-Oct-2024 ParkerWhite Names Luke Lauer as New Chief Executive Officer AccessWire
23-Oct-2024 AGS Health’s Fax Automation Solution Honored by UiPath with Prestigious AI25 Award AccessWire
23-Oct-2024 Luna Diabetes Announces Start of Pivotal Study to Bring Automated Insulin Delivery to Insulin Pens AccessWire
23-Oct-2024 Lab supplier highlights sustainable practices at Lab Innovations Scientific Laboratory Supplies
23-Oct-2024 Bioptimus And Proscia Collaborate To Accelerate AI Innovation In Scientific Research And Drug Development For Improved Patient Care Proscia
23-Oct-2024 CluePoints Wins Growth Award at BVA Private Equity Awards CluePoints
23-Oct-2024 Primum Appoints Erica Conroy as CEO, Strengthening Ohio’s Role in Revolutionizing Cancer Care AccessWire
23-Oct-2024 Ten businesses embark on Discovery Park’s ‘Discovery Spark’ programme Discovery Park
23-Oct-2024 Watson-Marlow Fluid Technology Solutions to showcase peristaltic filling machines and new single-use solutions at PACK EXPO International 2024 Watson-Marlow Fluid Technology Group
23-Oct-2024 Nitches, Inc. Unveils InTheZone Focused Extreme: A Premium Supplement for Enhanced Focus and Cognitive Performance Newswire
23-Oct-2024 New genetic screening programme should be extended to test for untreatable conditions, says leading biotech Innovate UK
23-Oct-2024 New genetic screening programme should be extended to test for untreatable conditions, says leading biotech SynaptixBio
23-Oct-2024 ProQR Announces Proposed Underwritten Public Offering of Ordinary Shares ProQR Therapeutics
23-Oct-2024 ProQR Prices $75 Million Underwritten Public Offering and Concurrent Private Placement ProQR Therapeutics N.V.
23-Oct-2024 ProQR Prices $75 Million Underwritten Public Offering and Concurrent Private Placement ProQR Therapeutics
23-Oct-2024 4Tissue Raises €2M to Advance Groundbreaking Breast Tissue Replacement Technology 4Tissue